EXECUTIVE EMPLOYMENT AGREEMENT
EXHIBIT 10.29
EXECUTION COPY
EXECUTIVE EMPLOYMENT AGREEMENT
THIS AGREEMENT (the “Agreement”) is entered into as of the 21st day of February, 2003, by and among RIBAPHARM INC. (the “Company”), and Xxx X. Xxxxx, MD, PhD, an individual (the “Executive”) (hereinafter collectively referred to as “the parties”).
The Company desires to employ Executive and Executive desires to be employed by the Company, all pursuant to the terms and conditions hereinafter set forth.
2. Employment. During the term of Executive’s employment under this Agreement:
(a) Subject to the terms and conditions of this Agreement, Executive shall be employed as President and Chief Executive Officer of the Company. Executive agrees to discharge all of the duties normally associated with such positions, to faithfully and to the best of his abilities perform such other services consistent with his position as a senior executive as may from time to time be assigned to him by the Company’s Board of Directors (the “Board”), and to devote all of his business time, skill and attention to such services. Executive agrees that he shall not engage in any other business activities of any kind which would give rise to a conflict of interest for Executive with respect to his duties and obligations to the Company.
(b) Executive shall report directly to the Board .
(c) Executive shall participate in all meetings of the Board (other than executive sessions and those meetings or portions of meetings specifically identified in advance, at which Executive’s performance will be discussed), unless, in its reasonable discretion, the Board determines that a conflict exists which requires it to exclude Executive from a meeting.
3. Compensation. During the term of Executive’s employment under this Agreement:
(d) Stock Options/Restricted Shares.
-2-
4. Other Benefits. During the term of Executive’s employment under this Agreement:
-3-
to utility companies in the ordinary course and scheduled hazard insurance premiums (collectively, the “Reimbursable Costs”), for the period beginning on the Start Date and ending on the earlier of (i) the first anniversary of the Start Date and (ii) the date on which Executive sells his existing residence. To the extent Executive is obligated to pay any federal (including without limitation, Social Security and Medicare taxes), state or local income taxes (collectively, “Income Taxes”) with respect to the Reimbursable Costs paid by the Company to Executive hereunder, other than those Reimbursable Costs which are subject to deduction by Executive in connection with Executive’s Income Taxes generally (collectively, the “Taxable Reimbursable Costs”), the Company shall pay to Executive the sum of (x) all Income Taxes due as a result of the payment of such Taxable Reimbursable Costs by the Company and (y) an amount equal to any and all Income Taxes paid or required to be paid with respect to the receipt by Executive of the amount set forth in clause (x) above (including, without limitation, any taxes on such additional amount).
(g) Office and Facilities. Executive shall be provided with an appropriate office in Costa Mesa, California, with such secretarial and other support facilities as are commensurate with Executive’s status with the Company and adequate for the performance of his duties hereunder.
(i) Executive shall be entitled to annual vacation in accordance with the policies as periodically established by the Board for similarly situated executives of the Company, which shall in no event be less than four weeks per year;
(ii) in addition to the aforesaid paid vacations, Executive shall be entitled, without loss of pay, to absent himself voluntarily from the performance of his employment for such additional periods of time and for such valid and legitimate reasons as the
-4-
Board in its discretion may determine, including time needed to judiciously terminate current business relationships of SciPharma Consulting, LLC with its clients . Further, the Board shall be entitled to grant to Executive a leave or leaves of absence with or without pay at such time or times and upon such terms and conditions as the Board in its discretion may determine; and
(iii) Executive shall be entitled to sick leave (without loss of pay) in accordance with the Company’s policies as in effect from time to time.
-5-
Company’s code of corporate conduct; or (D) failed, after written notice from the Company to render services to the Company in accordance with this Agreement or Executive’s position and responsibilities with the Company in a manner that amounts to gross neglect in the performance of his duties to the Company. The Company may suspend Executive, without pay, upon Executive’s indictment for the commission of (1) a felony or (2) a crime involving fraud, dishonesty or moral turpitude. Such suspension may remain effective until such time as the indictment is either dismissed or a verdict of not guilty has been entered, at which time Executive shall be reinstated with the Company. Upon such reinstatement, Executive shall be entitled to payment by the Company of all Base Salary to which Executive would have otherwise been entitled to during the period of such suspension.
-6-
-7-
(i) any accrued and unpaid Base Salary;
(ii) reimbursement for any and all monies advanced to Executive or expenses incurred in connection with Executive’s employment for reasonable and necessary expenses incurred by Executive on behalf of the Company for the period ending on the termination date;
(iii) any accrued and unpaid vacation pay; and
(iv) any previous compensation which Executive has previously deferred (including any interest earned or credited thereon), subject to the terms and conditions of the applicable deferred compensation plans then in effect (the foregoing items in Section 7(a)(i) through 7(a)(iv) being collectively referred to as the “Accrued Compensation”).
(i) any Accrued Compensation through the date of termination of employment;
(ii) if termination of Executive’s employment occurs during fiscal year 2003, an amount equal to the Guaranteed Bonus multiplied by a fraction (A) the numerator of which is the number of days in such fiscal year through the termination date, and (B) the denominator of which is 365;
(iii) if termination of Executive’s employment occurs after the end of fiscal year 2003, an amount equal to the target bonus or incentive award that Executive would have been entitled to receive in respect of the fiscal year in which Executive’s termination date occurs, had he continued in employment until the end of such fiscal year, calculated as if all performance targets and goals (if applicable) had been fully met by the Company and by Executive, as applicable, for such fiscal year, multiplied by a fraction (A) the numerator of which is the number of days in such fiscal year through the termination date and (B) the denominator of which is 365 (a “Pro Rata Bonus”); and
(iv) the Initial Stock Option shall become fully (100%) and immediately exercisable.
Executive’s entitlement to any other compensation or benefits hereunder shall be determined in accordance with the Company’s employee benefit plans and other applicable programs and practices then in effect.
-8-
(i) any Accrued Compensation through the date of termination of employment; and
(ii) If Executive voluntarily elects and agrees not to engage in Prohibited Activities (as hereinafter defined) for a period of one (1) year after the date of such termination of employment, the Company shall pay Executive as additional compensation for the periods subsequent to the termination date, an amount in cash equal to two (2) times the sum of (A) Executive’s annual Base Salary at the highest rate in effect at any time within the ninety (90) day period ending on the date the Notice of Termination is delivered, and (B) the Bonus Amount (as defined below). The additional compensation provided in the previous sentence shall be payable in substantially equal monthly installments for a period of twelve months. If Executive does not so voluntarily elect and agree or otherwise engages in such Prohibited Activities, then Executive’s eligibility to receive the post-employment benefits provided for in this Section 7(c)(ii) shall immediately thereafter terminate. For purposes of this Section 7(c), “Bonus Amount” shall mean the average annual cash bonus or incentive compensation received by Executive by virtue of Section 3(c) above during the two fiscal years immediately preceding the termination date. In the event Executive’s termination occurs during the 2003 fiscal year, “Bonus Amount” shall be an amount equal to the Guaranteed Bonus. In the event Executive’s termination occurs in the 2004 fiscal year, then the “Bonus Amount” shall mean the (i) sum of the cash bonus received by Executive by virtue of Section 3(c) above for the 2003 fiscal year plus the cash bonus Executive otherwise would have been entitled to receive by virtue of Section 3(c) above for the 2004 fiscal year had Executive remained employed by the Company for such fiscal year based on the performance of Executive and the Company, divided by (ii) 2. Executive’s entitlement to any other compensation or benefits hereunder shall be determined in accordance with the Company’s employee benefit plans and other applicable programs and practices then in effect. For the purposes of this Agreement, the term “Prohibited Activities” means directly or indirectly engaging as an owner, employee, consultant or agent of any entity that manufactures, markets and distributes (directly or indirectly through related entities, joint ventures, strategic alliances or other affiliated entities) prescription or non-prescription pharmaceuticals or medical devices for treatments in the fields of dermatology, oncology or hepatology (each a “Competitive Business”). Notwithstanding the foregoing, it shall not be considered a “Prohibited Activity” for Executive (i) to own or purchase any corporate securities of any entity that is regularly traded on a recognized stock exchange or over-the-counter market so long as Executive does not own, in the aggregate, 5% or more of the voting equity securities of any such entity or (ii) to perform consulting services for an entity engaged in a Competitive Business to the extent Executive has given the Company and ICN at least 30 days advance notice of Executive’s desire to perform such consulting services and both the Company’s Board of Directors and ICN’s Board of Directors (or the board of directors of a successor entity to the Company or ICN, as the case may be), in their sole and absolute discretion, have consented in writing to the performance of such consulting services by Executive.
(d) Termination Due to Non-Renewal of Term of Agreement.
(i) If the Company notifies Executive under Section 1 hereof that it shall not extend the Term of Agreement for any Renewal Period, Executive shall, subject to the provisions of Section 7(c) above, be entitled to the benefits provided in Section 7(c) above.
-9-
(ii) If Executive notifies the Company under Section 1 hereof that he shall not extend the Term of Agreement for any Renewal Period, Executive shall be entitled to any Accrued Compensation through the effective date of Executive’s termination.
(i) for a number of months equal to the lesser of (A) twenty-four (24), or (B) the number of months remaining until Executive’s 65th birthday, the Company shall at its expense continue on behalf of Executive and his dependents and beneficiaries the life insurance, disability, medical, dental and hospitalization benefits which were being provided to Executive at the time Notice of Termination is given. In the event that the provisions of any such employee benefit arrangements do not permit continuing coverage, then the Company shall provide Executive with substantially equivalent coverage through other sources. The benefits provided in this Section 7(e)(ii) shall be no less favorable to Executive, in terms of amounts and deductibles and costs to him, than the coverage provided Executive under the plans providing such benefits at the time Notice of Termination is given. The Company’s obligation hereunder with respect to the foregoing benefits shall be limited to the extent that Executive obtains any such benefits pursuant to a subsequent employer’s benefit plans, in which case the Company may reduce the coverage of any benefits it is required to provide Executive hereunder as long as the aggregate coverage of the combined benefit plans is no less favorable to Executive, in terms of amounts and deductibles and costs to him, than the coverage required to be provided hereunder. This Subsection (ii) shall not be interpreted so as to limit any benefits to which Executive or his dependents may be entitled under any of the Company’s employee benefit plans, programs or practices following Executive’s termination of employment, including without limitation, retiree medical and life insurance benefits;
(ii) all restrictions on any outstanding awards granted by the Company or any subsidiaries or parent of the Company (including restricted stock awards) granted to Executive shall lapse and such awards shall become fully (100%) and immediately vested, and all stock options and stock appreciation rights granted to Executive shall become fully (100%) and immediately exercisable;
(iii) if prior to a termination to which this Section 7(e) relates, the Company shall adopt a supplemental and excess retirement plan which covers Executive, then the Company shall pay in twenty-four (24) substantially equal monthly payments an amount in cash equal to the excess of (A) the actuarial equivalent of the aggregate retirement benefit Executive would have been entitled to receive under such supplemental and excess retirement plans (x) had Executive remained employed by the Company for an additional two (2) complete years of credited service (or until his 65th birthday, if earlier), (y) had Executive’s annual compensation during such period been equal to his Base Salary (at the rate used for purposes of
-10-
Section 7(c)(ii)) plus the Bonus Amount, and (z) had Executive been fully (100%) vested in his benefits under each such retirement plan with respect to his years of service prior to termination and such additional two (2) year period, over (B) the actuarial equivalent of the aggregate retirement benefit Executive is actually entitled to receive under such retirement plans. For purposes of this Subsection (iii), “actuarial equivalent” shall be determined in accordance with the actuarial assumptions used for the calculation of benefits under any retirement plan as applied prior to the termination date in accordance with such plan’s past practices (but shall in any event take into account the value of any subsidized early retirement benefit); and
(iv) In lieu of the amounts otherwise due to Executive in accordance with Section 7(c)(ii), the Company shall pay Executive as additional compensation for the periods subsequent to the termination date, an amount in cash equal to three (3) times the sum of (A) Executive’s annual Base Salary at the highest rate in effect at any time within the ninety (90) day period ending on the date the Notice of Termination is delivered, and (B) the Bonus Amount as defined in Section 7(c)(ii). The additional compensation provided in the previous sentence shall be payable in substantially equal monthly installments for a period of twelve months.
If Executive does not so voluntarily elect and agree or otherwise engages in such Prohibited Activities, then Executive’s eligibility to continue to receive the post-employment benefits provided for in this paragraph shall immediately thereafter terminate.
Executive shall not be required to mitigate the amount of any payment provided for under this Section 7 by seeking other employment and no such payment shall be offset or reduced by the amount of any compensation or benefits provided to Executive in any subsequent employment.
(a) the acquisition (other than from the Company) by any person (as such term is defined in Section 13(c) or 14(d) of the Securities Exchange Act of 1934, as amended (the “1934 Act”)) of beneficial ownership (within the meaning of Rule 13d-3 promulgated under the 0000 Xxx) of thirty -percent (30%) or more of the combined voting power of the Company’s then outstanding voting securities;
(b) the individuals who, as of the date hereof, are members of the Board (the “Incumbent Board”), cease for any reason to constitute at least two thirds (2/3) of the Board, unless the election, or nomination for election by the Company’s stockholders, of any new director was approved by a vote of at least two thirds (2/3) of the Incumbent Board, and such new director shall, for purposes of this Agreement, be considered as a member of the Incumbent Board;
(c) approval by stockholders of the Company of:
-11-
(i) a merger or consolidation involving the Company and an independent third party if the stockholders of the Company, immediately before such merger or consolidation, do not, as a result of such merger or consolidation, own, directly or indirectly, more than seventy percent (70%) of the combined voting power of the then outstanding voting securities of the corporation resulting from such merger or consolidation in substantially the same proportion as their ownership of the combined voting power of the voting securities of the Company outstanding immediately before such merger or consolidation; or
(ii) an agreement for the sale or other disposition of all or substantially all of the assets of the Company to an independent third party;
(d) the liquidation or dissolution of ICN ;
(e) the individuals who, as of the date hereof, are members of the Board of Directors of ICN (the “ICN Board”), cease for any reason to constitute at least two thirds (2/3) of the ICN Board, unless the election, or nomination for election by ICN’s stockholders, of any new director was approved by a vote of at least two thirds (2/3) of the ICN Board, and such new director shall, for purposes of this Agreement, be considered as a member of the ICN Board;
(f) approval by stockholders of ICN of:
(i) a merger or consolidation involving ICN and an independent third party if the stockholders of ICN, immediately before such merger or consolidation, do not, as a result of such merger or consolidation, own, directly or indirectly, more than seventy percent (70%) of the combined voting power of the then outstanding voting securities of the corporation resulting from such merger or consolidation in substantially the same proportion as their ownership of the combined voting power of the voting securities of ICN outstanding immediately before such merger or consolidation; or
(g) an agreement for the sale or other disposition of all or substantially all of the assets of ICN to an independent third party.
Notwithstanding the foregoing, a Change in Control shall not be deemed to occur pursuant to Section 8(a), solely because thirty percent (30%) or more of the combined voting power of the Company’s then outstanding securities is acquired by (i) a trustee or other fiduciary holding securities under one or more employee benefit plans maintained by the Company or any of its subsidiaries or (ii) any corporation which, immediately prior to such acquisition, is owned directly or indirectly by the stockholders of the Company in the same proportion as their ownership of stock in the Company immediately prior to such acquisition. In no event shall any reduction in the equity interest of ICN in the Company be deemed to constitute a “Change in Control” hereunder.
-12-
date of such transaction (the “Closing Date”) shall be converted into stock options to purchase such number of shares of common stock of ICN, par value $.01 per share, under ICN’s 1998 Stock Option Plan (the “Converted Options”) determined by multiplying the number of outstanding unexercised options identified above by a fraction, (A) the numerator of which shall be the Fair Market Value Shares (as defined below) and (B) the denominator of which shall be the Number of Shares (as defined below). The exercise price of the Converted Options shall be established by multiplying the applicable exercise price of the outstanding unexercised option being converted by a fraction, (A) the numerator of which is the Number of Shares and (B) the denominator of which is the Fair Market Value Shares. The Converted Options will contain substantially similar terms as the Initial Stock Options and the Future Stock Options, if any, including vesting, as of the Closing Date.
For purposes of this Section 9, “Fair Market Value Shares” shall mean the fair market value of the securities, cash, other assets or combination thereof offered to the Company’s stockholders in the Acquisition, divided by the average closing price of a share of common stock of ICN for the five trading days immediately preceding the public announcement of the Acquisition. “Number of Shares” shall mean (A) that number of shares of Common Stock acquired by ICN in connection with the Acquisition, or (B) in the case of an Acquisition in which the Company’s assets are acquired by ICN, the equivalent number of shares as determined by dividing the fair market value of such assets divided by the average closing price of a share of Common Stock for the five trading days immediately preceding the public announcement of the Acquisition.
-13-
reasonably determines that Executive is required to pay excise tax, interest or penalties to a governmental taxing authority as a result of his non-payment of taxes where such tax counsel had determined that such taxes need not be paid, the Company shall pay to Executive an additional amount equal to (A) the amount of such interest and/or penalties, (B) the excise tax which was not paid and (C) any excise tax and any other taxes imposed by the Code or under state or local law on the payments provided for in this sentence.
11. Records and Confidential Data; Proprietary Inventions.
(a) Executive acknowledges that in connection with the performance of his duties during the Term of Agreement the Company will make available to Executive, or Executive will have access to, certain Confidential Information (as defined below) of the Company and its affiliates. Executive acknowledges and agrees that any and all Confidential Information learned or obtained by Executive during the course of his employment by the Company or otherwise, whether developed by Executive alone or in conjunction with others or otherwise, shall be and is the property of the Company and its affiliates.
(b) The Confidential Information will be kept confidential by Executive, will not be used in any manner which is detrimental to the Company, will not be used other than in connection with Executive’s discharge of his duties hereunder, and will be safeguarded by Executive from unauthorized disclosure.
(c) For the purposes of this Agreement, “Confidential Information” shall mean all confidential and proprietary information of the Company and its affiliates that has been created, discovered or developed or has otherwise become known to the Company (including, without limitation, information created, discovered, developed or made known by or to Executive during the period of or arising out of his employment hereunder) or in which property rights have been assigned or otherwise conveyed to the Company, which information has commercial value in the business in which the Company is engaged; by way of illustration and not by limitation, Confidential Information includes information derived from reports, investigations, experiments, research, work in progress, drawing, designs, plans, proposals, codes, marketing and sales programs, client lists, client mailing lists, supplier lists, financial projections, cost summaries, pricing formula, marketing studies relating to prospective business opportunities and all other concepts, ideas, materials, or information prepared or performed for or by the Company or its affiliates. For purposes of this Agreement, the Confidential Information shall not include and Executive’s obligation’s shall not extend to (i) information which is or becomes, without violation by Executive of this Agreement, generally available to the public and (ii) information obtained by Executive other than pursuant to or in connection with this employment. Notwithstanding the foregoing, if Executive is required by law or legal process to disclose the Confidential Information, Executive shall provide the Company with prompt notice so that the Company may seek a protective order or other appropriate remedy and/or waive compliance with this Section 11. If, in the absence of a protective order or other remedy or the receipt of a waiver by the Company, Executive is nonetheless, in the opinion of counsel, legally compelled to disclose the Confidential Information, Executive may, without liability hereunder, disclose only that portion of the Confidential Information which such counsel advises is legally required to be disclosed, provided, however, that Executive exercise reasonable efforts to preserve the confidentiality of the Confidential Information, including
-14-
without limitation, cooperating with the Company to obtain an appropriate protective order or other reliable assurance that confidential treatment will be accorded the Confidential Information.
(d) Executive hereby assigns to the Company any rights he may acquire during his employment hereunder in all Confidential Information and .agrees that all Inventions (as defined below) will be the sole property of the Company and its assigns, and the Company and its assigns will be the sole owner of all the patents and other rights in connection therewith. Executive hereby assigns to the Company any rights he may acquire during the period of his employment hereunder in all Inventions and agrees to assist the Company in every proper way (but at the Company’s expense) to obtain and from time to time enforce patents on Inventions in any and all countries. Executive shall execute all documents for use in applying for and obtaining such patents thereon and enforcing same, as the Company may desire, together with any assignments thereof to the Company or persons designated by it. Executive’s obligation to assist the Company in obtaining and enforcing patents for Inventions in any and all countries will continue beyond the termination of employment hereunder, but the Company will compensate Executive at a reasonable rate after such termination for time actually spent by him at the Company’s request on such assistance. Executive acknowledges that, in accordance with Section 2872 of the California Labor Code, the assignment provisions in this paragraph (d), do not apply to Inventions for which no equipment, supplies, facility, or trade secret information of the Company was used, which were developed entirely on Executive’s own time, and (i) which do not relate (a) to the business of the Company or (b) to the Company’s actual or demonstrably anticipated research or development or (ii) which do not result from any work performed by Executive for the Company. Executive has identified on Schedule I hereto all inventions or improvements relevant to the subject matter of Executive’s employment hereunder which have been made or conceived or first reduced to practice by Executive alone or jointly with others prior to the date hereof which Executive desires to remove from the operation of this Agreement; and Executive represents that such list is complete. If there is no such list on Schedule I, Executive represents that he has made no such inventions and improvements as of the date hereof.
(e) For purposes of this Agreement, “Inventions” shall mean all improvements, inventions, formulae, processes, techniques, know-how and data whether or not patentable, made or conceived or reduced to practice or learned by Executive, either alone or jointly with others, during Executive’s employment hereunder which are related to or useful in the business of the Company, or result from tasks assigned Executive by the Company, or result from use of premises owned, leased or contracted for by the Company.
(f) Executive’s obligations under this Section 11 shall survive the termination of the Term of Agreement.
-15-
the Company. For purposes of this covenant, “solicit” or “solicitation” means directly or indirectly influencing or attempting to influence employees or consultants of the Company to become employed with any other person, partnership, firm, corporation or other entity. Executive agrees that the covenants contained in this Section 12 are reasonable and desirable to protect the Confidential Information of the Company.
(b) It is the intent and desire of Executive and the Company that the restrictive provisions of this Section 12 be enforced to the fullest extent permissible under the laws and public policies as applied in each jurisdiction in which enforcement is sought. If any particular provision of this Section 12 shall be determined to be invalid or unenforceable, such covenant shall be amended, without any action on the part of either party hereto, to delete therefrom the portion so determined to be invalid or unenforceable, such deletion to apply only with respect to the operation of such covenant in the particular jurisdiction in which such adjudication is made.
(c) Executive’s obligations under this Section 12 shall survive the termination of the Term of Agreement.
(i) This Agreement shall be binding upon and shall inure to the benefit of the Company, its successors and assigns and the Company shall require any successor or assign to expressly assume and agree to perform this Agreement in the same manner and to the
-16-
same extent that the Company would be required to perform if no such succession or assignment had taken place. The term “the Company” as used herein shall mean a corporation or other entity acquiring all or substantially all the assets and business of the Company (including this Agreement) whether by operation of law or otherwise.
(ii) Neither this Agreement nor any right or interest hereunder shall be assignable or transferable by Executive, his beneficiaries or legal representatives, except by will or by the, laws of descent and distribution. This Agreement shall inure to the benefit of and be enforceable by Executive’s legal personal representatives.
-17-
(g) Arbitration. If any legally actionable dispute arises under this Agreement or otherwise which cannot be resolved by mutual discussion between the parties, then the Company and Executive each agree to resolve that dispute by binding arbitration before an arbitrator experienced in employment law. Said arbitration will be conducted in accordance with the rules applicable to employment disputes of the Judicial Arbitration and Mediation Services (“JAMS”) and the law applicable to the claim. The parties shall have 30 calendar days after notice of such arbitration has been given to attempt to agree on the selection of an arbitrator. In the event the parties are unable to agree in such time, JAMS will provide a list of nine available arbitrators and an arbitrator will be selected from such nine-member panel provided by JAMS by the parties alternately striking out one name of a potential arbitrator until only one name remains. The party entitled to strike an arbitrator first shall be selected by a toss of a coin. The parties agree that this agreement to arbitrate includes any such disputes that the Company may have against Executive, or Executive may have against the Company and/or its related entities and/or employees, arising out of or relating to this Agreement, or Executive’s employment or Executive’s termination including, but not limited to, any claims of discrimination or harassment in violation of applicable law and any other aspect of Executive’s compensation, employment, or Executive’s termination. The parties further agree that arbitration as provided for in this Section 14(g) is the exclusive and binding remedy for any such dispute and will be used instead of any court action, which is hereby expressly waived, except for any request by either party for temporary or preliminary injunctive relief pending arbitration in accordance with applicable law or for breaches by Executive of Executive’s obligations under Sections 11 or 12 above or an administrative claim with an administrative agency. The parties agree that the arbitration provided herein shall be conducted in Orange County, California unless otherwise mutually agreed or unless Executive’s primary place of employment is a different location. The Company shall pay the cost of any arbitration brought pursuant to this paragraph, including filing fees, administrative fees and the costs of the arbitrator, excluding, however, the filing fees of Executive if he is the moving party to the extent such fees are equal to or less than those that would applicable to file a complaint in the Orange County Superior Court and the cost of representation of Executive unless such cost is awarded in accordance with law or otherwise awarded by the arbitrators.
(h) Governing Law. This Agreement shall be governed by and construed and enforced in accordance with the laws of the State of California applicable to contracts executed in and to be performed entirely within such State, without giving effect to the conflict of law principles thereof.
-18-
secrets or confidential information. Accordingly, to the extent Executive is under such an obligation, Executive shall not: (a) bring any records, notes, files, drawings, documents, plans and like items, provided to him in confidence by such other company, or any copies thereof, relating to or containing or disclosing confidential information or trade secrets of any such other company on the premises of the Company or otherwise use such documents and items in the performance of services for the Company; or (b) disclose any confidential information or trade secrets provided to Executive in confidence by such other company to any other employee of the Company; provided, however, that this prohibition only applies to documents or information that Executive obtained or learned before the beginning of his relationship with the Company.
[Signature Page Follows]
\
-19-
RIBAPHARM INC. | ||
By: |
/s/ XXXXXX X. XXXXXXX | |
Name: Title: |
Xxxxxx X. Xxxxxxx Chairman of the Board |
EXECUTIVE | ||
By: |
/s/ XXX X. XXXXX | |
Name: |
Xxx X. Xxxxx, M.D., Ph.D. |
-20-